These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32590616)

  • 1. Malignant Insulinoma Is Largely Derived From Nonfunctioning Pancreatic Neuroendocrine Tumors: A Contemporary View.
    Yu R
    Pancreas; 2020 Jul; 49(6):733-736. PubMed ID: 32590616
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region.
    Nakakura EK; Bergsland EK
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):457-73; viii. PubMed ID: 17548034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic neuroendocrine tumors: contemporary diagnosis and management.
    Parbhu SK; Adler DG
    Hosp Pract (1995); 2016 Aug; 44(3):109-19. PubMed ID: 27404266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumors of the pancreas.
    Miglani A; Kar P
    Trop Gastroenterol; 2006; 27(1):4-10. PubMed ID: 16910053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique case of a nonfunctional metastatic pancreatic neuroendocrine tumor transforming into an insulin-secreting tumor with an unusual clinical course.
    Vashi PG; Gupta D; Dahlk S
    Pancreas; 2011 Jul; 40(5):781-4. PubMed ID: 21673539
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumors of the pancreas.
    Dadan J; Wojskowicz P; Wojskowicz A
    Wiad Lek; 2008; 61(1-3):43-7. PubMed ID: 18717042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pancreatic neuroendocrine tumors].
    Burgos L; Burgos ME
    Rev Med Chil; 2004 May; 132(5):627-34. PubMed ID: 15279151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
    Sadanandam A; Wullschleger S; Lyssiotis CA; Grötzinger C; Barbi S; Bersani S; Körner J; Wafy I; Mafficini A; Lawlor RT; Simbolo M; Asara JM; Bläker H; Cantley LC; Wiedenmann B; Scarpa A; Hanahan D
    Cancer Discov; 2015 Dec; 5(12):1296-313. PubMed ID: 26446169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet cell tumors.
    Mittendorf EA; Shifrin AL; Inabnet WB; Libutti SK; McHenry CR; Demeure MJ
    Curr Probl Surg; 2006 Oct; 43(10):685-765. PubMed ID: 17055796
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of malignant pancreatic endocrine tumour.
    Wang L; Zhao YP; Lee CI; Liao Q
    Chin Med Sci J; 2004 Jun; 19(2):130-3. PubMed ID: 15250251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumors.
    Krampitz GW; Norton JA
    Curr Probl Surg; 2013 Nov; 50(11):509-45. PubMed ID: 24206780
    [No Abstract]   [Full Text] [Related]  

  • 13. PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform.
    Liu SH; Rao DD; Nemunaitis J; Senzer N; Zhou G; Dawson D; Gingras MC; Wang Z; Gibbs R; Norman M; Templeton NS; Demayo FJ; O'Malley B; Sanchez R; Fisher WE; Brunicardi FC
    PLoS One; 2012; 7(8):e40452. PubMed ID: 22905092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant insulinoma: recommendations for workup and treatment].
    Baudin E; Caron P; Lombard-Bohas C; Tabarin A; Mitry E; Reznick Y; Taieb D; Pattou F; Goudet P; Vezzosi D; Scoazec JY; Cadiot G; Borson-Chazot F; Do Cao C;
    Presse Med; 2014 Jun; 43(6 Pt 1):645-59. PubMed ID: 24857257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
    Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
    Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma.
    Yao JC
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):163-72. PubMed ID: 17382271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
    Hofland J; Falconi M; Christ E; Castaño JP; Faggiano A; Lamarca A; Perren A; Petrucci S; Prasad V; Ruszniewski P; Thirlwell C; Vullierme MP; Welin S; Bartsch DK
    J Neuroendocrinol; 2023 Aug; 35(8):e13318. PubMed ID: 37578384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic endocrine tumors].
    Kochatkov AV; Kriger AG; Gorin DS; Lebedeva AN
    Khirurgiia (Mosk); 2010; (9):71-80. PubMed ID: 21513034
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of mixed duct-islet cell tumor of the pancreas].
    Iwamuro M; Kubota J; Saito S; Goubaru M; Ohta T; Ogata M; Takuma Y; Tanaka S; Makino Y; Murakami I
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jun; 104(6):829-36. PubMed ID: 17548951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms.
    Jiang R; Hong X; Zhao Y; Wu W
    Cancer Lett; 2021 Feb; 499():39-48. PubMed ID: 33246093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.